(D20) Benign neoplasm of soft tissue of retroperitoneum and peritoneum

More details coming soon

Icon
65 938 in individuals diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum confirmed
Icon
1 347 deaths with diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum
Icon
2% mortality rate associated with the disease benign neoplasm of soft tissue of retroperitoneum and peritoneum

Diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum is diagnosed Women are 44.66% more likely than Men

18 245

Men receive the diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum

668 (3.7 %)

Died from this diagnosis.

100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
47 693

Women receive the diagnosis benign neoplasm of soft tissue of retroperitoneum and peritoneum

679 (1.4 %)

Died from this diagnosis.

Risk Group for the Disease benign neoplasm of soft tissue of retroperitoneum and peritoneum - Men aged 50-54 and Women aged 35-39

Icon
In Men diagnosis is most often set at age 0-1, 5-84
Icon
Less common in men the disease occurs at Age 0-5, 85-95+Less common in women the disease occurs at Age 90-95+
Icon
In Women diagnosis is most often set at age 0-89

Disease Features benign neoplasm of soft tissue of retroperitoneum and peritoneum

Icon
Absence or low individual and public risk
Icon

Benign neoplasm of soft tissue of retroperitoneum and peritoneum - what does this mean

Benign neoplasm of soft tissue of retroperitoneum and peritoneum is a condition that occurs when cells in the soft tissues of the retroperitoneum and peritoneum grow and divide abnormally, forming a mass of tissue called a tumor. these tumors are usually benign, meaning they are not cancerous. symptoms may include abdominal pain, bloating, and weight loss. treatment may involve surgery to remove the tumor and any affected tissue.

What happens during the disease - benign neoplasm of soft tissue of retroperitoneum and peritoneum

Benign neoplasm of soft tissue of retroperitoneum and peritoneum is caused by abnormal growth of cells in the soft tissue of the retroperitoneum and peritoneum. this growth is usually slow and is not caused by any infectious agent. it is often caused by genetic mutations or environmental factors, such as radiation or certain chemicals. the cells in the neoplasm may be benign, but can become malignant if left untreated.

Clinical Pattern

A benign neoplasm of soft tissue of retroperitoneum and peritoneum is a slow-growing, localized mass of abnormal cells that originate from the peritoneal and retroperitoneal tissue. It may present with abdominal pain, distension, and a palpable mass. It is usually discovered incidentally on imaging studies. Treatment typically involves surgical resection.

How does a doctor diagnose

  • Physical examination
  • Ultrasound
  • CT scan
  • MRI
  • Biopsy
  • Surgery
  • Chemotherapy
  • Radiation therapy

Treatment and Medical Assistance

Main goal of the treatment: To reduce the size of the benign neoplasm and to prevent its recurrence.
  • Surgery
  • Chemotherapy
  • Radiation therapy
  • Cryotherapy
  • Immunotherapy
  • Hormone therapy
  • Targeted therapy
Icon
11 Days of Hospitalization Required
Icon
Average Time for Outpatient Care Not Established

Benign neoplasm of soft tissue of retroperitoneum and peritoneum - Prevention

The best way to prevent benign neoplasms of soft tissue of retroperitoneum and peritoneum is to maintain a healthy lifestyle by eating a balanced diet, exercising regularly, and avoiding smoking and excessive alcohol consumption. additionally, regular check-ups with a healthcare provider can help identify any potential issues early on, allowing for timely treatment and prevention of further complications.

Specified forms of the disease

(Y47.0) Barbiturates, not elsewhere classified
(Y47.1) Benzodiazepines
(Y47.2) Cloral derivatives
(Y47.3) Paraldehyde
(Y47.4) Bromine compounds
(Y47.5) Mixed sedatives and hypnotics, not elsewhere classified
(Y47.8) Other sedatives, hypnotics and antianxiety drugs
(Y47.9) Sedative, hypnotic and antianxiety drug, unspecified